AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNYA
  4. [SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

[SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock TNYA logo
Tenaya Therapeutics, Inc.

NASDAQ:TNYA

TNYA Rankings

#4223 Ranked by Market Cap
N/A Ranked by Dividends

TNYA Latest News

Sep 2, 2025
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 31, 2025
Tenaya Therapeutics Presents Interim Data from MyClimb� Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025
Aug 8, 2025
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
Aug 6, 2025
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 30, 2025
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed

TNYA Latest SEC Filings

Aug 18, 2025
[Form 4] Tenaya Therapeutics, Inc. Insider Trading Activity
Aug 18, 2025
[Form 4] Tenaya Therapeutics, Inc. Insider Trading Activity
Aug 18, 2025
[Form 4] Tenaya Therapeutics, Inc. Insider Trading Activity
Aug 18, 2025
[144] Tenaya Therapeutics, Inc. SEC Filing
Aug 18, 2025
[144] Tenaya Therapeutics, Inc. SEC Filing

TNYA Stock Data

192.31M
161.37M
0.7%
22.21%
6.51%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SOUTH SAN FRANCISCO